The STING pathway and the T cell-inflamed tumor microenvironment
about
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapyThe emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applicationsSTING: infection, inflammation and cancerImmunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis.IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and ToleranceImmune escape to PD-L1/PD-1 blockade: seven steps to success (or failure).Reprogramming antitumor immunity against chemoresistant ovarian cancer by a CXCR4 antagonist-armed viral oncotherapy.Intracellular STING inactivation sensitizes breast cancer cells to genotoxic agents.Intratumoral immunotherapy for melanoma.The importance of the tumor microenvironment in the therapeutic management of cancer.Towards precision radiotherapy for use with immune checkpoint blockers.Gene Expression in Mouse Thyrotrope Adenoma: Transcription Elongation Factor Stimulates Proliferation.Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.Recent advances in immuno-oncology and its application to urological cancers.Nongenetic functions of the genome.Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancer.Improving vaccine efficacy against malignant gliomacGAS-cGAMP-STING: The three musketeers of cytosolic DNA sensing and signaling.Concise Review: An (Im)Penetrable Shield: How the Tumor Microenvironment Protects Cancer Stem Cells.Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy.Regulating STING in health and diseasep38 inhibition provides anti-DNA virus immunity by regulation of USP21 phosphorylation and STING activation.An RNA-Based Fluorescent Biosensor for High-Throughput Analysis of the cGAS-cGAMP-STING Pathway.Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis.2'-5' Oligoadenylate synthetase-like 1 (OASL1) deficiency in mice promotes an effective anti-tumor immune response by enhancing the production of type I interferons.A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists.Substrate-Dependence of Competitive Nucleotide Pyrophosphatase/Phosphodiesterase1 (NPP1) Inhibitors.STING Activation Reverses Lymphoma-Mediated Resistance to Antibody Immunotherapy.cGAS/STING Pathway in Cancer: Jekyll and Hyde Story of Cancer Immune Response.Adaptive Resistance to Cancer Immunotherapy.Molecular Biomarkers of Primary and Acquired Resistance to T-Cell-Mediated Immunotherapy in Cancer: Landscape, Clinical Implications, and Future Directions.Established T Cell-Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade.Extrachromosomal telomere repeat DNA is linked to ALT development via cGAS-STING DNA sensing pathway.NEMO-IKKβ Are Essential for IRF3 and NF-κB Activation in the cGAS-STING Pathway.Chemo-Immunotherapy: Role of Indoleamine 2,3-Dioxygenase in Defining Immunogenic Versus Tolerogenic Cell Death in the Tumor Microenvironment.Mechanisms regulating T-cell infiltration and activity in solid tumors.Small-Molecule Targets in Tumor ImmunotherapyPrognostic role of tumor-infiltrating lymphocytes in gastric cancer: A systematic review and meta-analysis
P2860
Q26745516-F74A1FAA-98FC-47A3-A0A7-D8A10E7FCCEDQ26747516-3C74757B-5E43-4474-9E2C-602C420A5A85Q26776009-CEB29954-C337-493E-85C9-498F8427934FQ28078539-5386EB06-9FB3-48A3-A212-699762330388Q33761491-59FB72B8-B74E-4266-9CA8-EE561984F235Q34512092-592A6C3A-E94F-4810-9BB0-A43CB0EE1D40Q36024656-3027844E-8EC8-4441-8007-C85314F40D00Q37502464-66EBC239-07C4-4347-A06F-BA0C28723703Q37718357-37782264-749E-418F-9D99-AEDF2D4C74D4Q38518518-08E50E07-02E9-41FD-9AF6-14991E1DCAD2Q38534294-D06E698A-CB4C-4CBE-9E3A-EC8F245BDD73Q38656599-76290801-5F27-4A66-AD29-FE13CF3AFA85Q38748843-9571B8E7-7716-4430-B8D6-5B40D38B32FCQ38796338-2324D05B-7BCE-4819-BAAE-518E52E70D55Q38819745-3C6A07BD-8C13-4423-B0B8-FAB14F171D1DQ38827314-F3D3EDF6-3713-45C0-8030-5296DB5AEE04Q38935248-3EBD4483-4666-4457-85B6-055808DCA319Q38953024-1050D0F0-9BC1-4A01-BD33-B962737E03DAQ38972881-CBF4DFBC-AF2D-4AE3-9A68-36135F2BBDFCQ39138664-B4D7C663-FB9F-4B93-9888-29245FF8E739Q39245218-80DFDA73-E564-4353-910F-E5CC87B7C973Q39360861-770A8DB0-B337-474C-8192-35BAA01E42C5Q40310541-3F8BFA8A-C08F-4CCF-A960-C27F3FF589B9Q40434927-03E0867B-F983-456F-A47F-3ED3174101CBQ40627933-AB7727DE-322E-44A4-9FD7-4442A0D2A3B9Q40732994-C6BEDCDD-A62E-418B-AE34-F0D2B07A42A8Q41923395-11643F01-F9E4-47C1-B767-4B4E1A22C258Q42321503-2FBDB2E3-4224-4853-B661-52FBF3DD0564Q47122380-6318D608-C247-45BF-8D43-CF6F5732C1ACQ47132136-2AE4D87A-9724-4F07-8E6C-9E7F3F9CFCEFQ47252744-A73C59BC-6DEE-4A25-8201-2F519F90BBB1Q47292249-C4140B18-6B47-4055-BF58-4D151EDF6B32Q47391699-BB47A97D-8025-48D0-B0CE-3DA02C33866CQ47438123-20EB93F2-7155-424E-8B95-FDC139B4DEA6Q47758471-09C5D3A0-3042-49E8-9C97-FABD975FD953Q49592881-B4293EB5-15D2-48AF-A61E-B435530F9E37Q50089395-20B1C5CF-A87F-43DC-B1DC-BDD07ACD5453Q56890719-776C82B9-1052-4D02-8DF1-DAA0C85FCF76Q58789034-083BD0B9-79D7-4E5F-A11D-72EFA4EE40E3
P2860
The STING pathway and the T cell-inflamed tumor microenvironment
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
The STING pathway and the T cell-inflamed tumor microenvironment
@ast
The STING pathway and the T cell-inflamed tumor microenvironment
@en
The STING pathway and the T cell-inflamed tumor microenvironment
@nl
type
label
The STING pathway and the T cell-inflamed tumor microenvironment
@ast
The STING pathway and the T cell-inflamed tumor microenvironment
@en
The STING pathway and the T cell-inflamed tumor microenvironment
@nl
prefLabel
The STING pathway and the T cell-inflamed tumor microenvironment
@ast
The STING pathway and the T cell-inflamed tumor microenvironment
@en
The STING pathway and the T cell-inflamed tumor microenvironment
@nl
P2093
P2860
P3181
P356
P1433
P1476
The STING pathway and the T cell-inflamed tumor microenvironment
@en
P2093
Leticia Corrales
Seng-Ryong Woo
Thomas F. Gajewski
P2860
P3181
P356
10.1016/J.IT.2015.02.003
P407
P577
2015-04-01T00:00:00Z